Alyftrek Reimbursed in Belgium: New Hope for Cystic Fibrosis Patients

Alyftrek Reimbursed in Belgium: New Hope for Cystic Fibrosis Patients

Mucoviscidose touches one in 20 Belgians as carriers, with a new diagnosis occurring every ten days through dual-parent gene transmission. Genetic mutations disrupt water regulation in cellular mucus layers, creating … Read More